Introduction
The primary system Kidd antigens (Jka and Jkb) play a key role in urea transport through the membrane of red blood cells (RBC) [1] . They are present in Kidd proteins, which are codified by codominant alleles of a gene expressed in erythrocytes, endothelial cells and other tissues. In 1951 Allen et al. [2] discovered the antigen Jka in a pregnant woman without transfusion history who delivered a newborn with mild hemolytic disease. The first case of alloimmunization during pregnancy by anti-Jkb was described 2 years later, in 1953, by Plaut et al. [3] . The frequency of both antigens is high in Caucasian population (77 % for Jka and 72 % for Jkb). Aproximately 20-29 % of caucasian and asian population have the Jk (a?b-) phenotype. Moreover, people with phenotype Jk (a-b-) are usually Asiatic. Kidd antibodies are usually IgG, which means they are capable of going through the placenta and bind the complement, producing hemolysis both intra and extravascular. They are not always detected by the routine techniques due to their tendency to decrease after the antigenic stimulus ends (52 % of the anti-Jk antibodies disappear within first months after exposure) [4] . This is the reason why they may produce severe immediate or delayed hemolytic transfusion reactions because of a strong anamnestic response in subsequent reexposure to similar antigen positive RBC. This occurs even when antibody levels are undetectable. Then, the alloimmunized individuals should be continued on lifelong transfusions of antigen-negative blood.
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Case Report
We report a case of a 41-years-old healthy pregnant woman, gravida 3, para 2 who was sent to the blood bank for study because of a positive antibody screening test. She had no history of any blood derivatives transfusion. None of her two previous children presented data of hemolytic disease. Follow-up was continued and anti-Jkb titer remained low during whole pregnancy. No data of anemia were noted in the fetus, thus no intrauterine transfusion was required. At August 10th of current year, our patient delivered a female infant after 40 weeks gestation. Her weight was 3.15 kg. The baby had no complications at birth and she was a normal fullterm infant, without jaundice or data of hemolysis.
Bloodtype B Rh(D) positive and phenotype Jkb? were confirmed in cord blood sample, with DAT and eluate negatives.
Forty eight hours after birth total serum bilirubin was 8.6 mg/dL. No data of haemoglobin or reticulocytes were available. Neither phototherapy nor exchange transfusion was needed, and the newborn as well as her mother were discharged 2 days after birth. The patient gave her informed consent prior to her inclusion in the study.
Discussion
The most common route of sensitization against Kidd antigens is via blood transfusion. Antibodies are usually IgG able to cross the placenta, bind complement and produce rapid either intravascular and/or extravascular hemolysis. In those fetal RBC-maternal blood contact cases, the sensitization is rare but possible.
The vast majority of cases of fetomaternal incompatibility are due to ABO sensitization, although most of severe HDN are produced by anti-RhD. The proportion of cases that has been caused by Kell, Duffy, Kidd and other systems is just around 3 % [5] [6] [7] [8] [9] [10] [11] . Kidd antigens can be detected from the 7th week of gestation and are well developed at birth. When alloimmunization occurs it can potentially lead to a HDN which usually has a mild clinical course and a good outcome. There are only thirteen cases of anti-Jkb related HDN reported in medical literature (Table 2) [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Most of them (76.92 %) were mild and the newborn required either phototherapy (4 cases: 30.76 %) or no treatment at all. Only Merlob's case needed red blood cell transfusion. Despite of these data, 2 cases (15.38 %) had a fatal outcome. One of them developed hidrops fetalis and intrauterine death [21] , and the second one died of acute renal failure 4 days after birth in spite of intensive treatment with exchange transfusion and phototherapy for 3 days [17] .
Our case differs from other good outcome cases on the absence of signs of hemolysis in the newborn. Unlike other reported cases, our patient's previous pregnancies were uneventful and her children had no jaundice at birth. Furthermore, antibody screenings were always negative until current gestation, so the certain moment of sensitization cannot be determined. Given the potential clinical significance of Kidd antibodies, periodical titer determinations were performed in our patient with the purpose of detecting the onset of fetal anemia early and performing intrauterine transfusion if necessary.
Although HDN of anti-Jkb incompatibility generally shows mild clinical symptoms and a favourable prognosis, severe anemia and hidrops fetalis can occur. Because of that antibody titer monitoring should be performed in every alloimmunizated pregnant, and a high-risk-pregnancy management by an expert consultant is recommended.
We consider routine antenatal antibody screening as an essential strategy to be carried out in every pregnant woman, irrespective of her Rh(D) phenotype, in order to detect red cell alloimmunization to other clinically significant blood group antigens such as Kidd, Duffy or Kell.
